Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TNFSF15 anticorps

L’anticorps Souris Monoclonal anti-TNFSF15 a été validé pour IHC (f). Il convient pour détecter TNFSF15 dans des échantillons de Humain.
N° du produit ABIN6938628

Aperçu rapide pour TNFSF15 anticorps (ABIN6938628)

Antigène

Voir toutes TNFSF15 Anticorps
TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))

Reactivité

  • 105
  • 38
  • 16
  • 5
  • 4
  • 4
  • 4
Humain

Hôte

  • 72
  • 34
  • 3
  • 1
Souris

Clonalité

  • 58
  • 49
  • 3
Monoclonal

Conjugué

  • 52
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp TNFSF15 est non-conjugé

Application

  • 65
  • 39
  • 28
  • 28
  • 26
  • 19
  • 13
  • 13
  • 10
  • 7
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

VEGI-1283
  • Specificité

    VEGI is an anti-angiogenic cytokine that belongs to tumor necrosis factor superfamily, member 15 (TNFSF15). This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Reduced expression of VEGI has been reported as a marker of poor prognosis in breast cancer.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant human VEGI fragment

    Isotype

    IgG1 kappa
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Endothelial cells. Colon, intestine, placenta, lung, liver, kidney, pancreas, spleen or prostate.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))

    Autre désignation

    TNFSF15

    Sujet

    TNF ligand-related molecule 1 (TL1A), Tumor necrosis factor (ligand) superfamily member 15 (TNFSF15), Vascular endothelial growth inhibitor 192a, Vascular endothelial growth inhibitor (VEGI), VEGI192A,TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor)
    Cellular localisation: Secreted and Cell Surface

    Poids moléculaire

    22kDa

    ID gène

    9966, 241382

    UniProt

    O95150

    Pathways

    Positive Regulation of Endopeptidase Activity, Autophagy
Vous êtes ici:
Chat with us!